These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28809440)

  • 1. Floating solid cellulose nanofibre nanofoams for sustained release of the poorly soluble model drug furosemide.
    Svagan AJ; Müllertz A; Löbmann K
    J Pharm Pharmacol; 2017 Nov; 69(11):1477-1484. PubMed ID: 28809440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid cellulose nanofiber based foams - Towards facile design of sustained drug delivery systems.
    Svagan AJ; Benjamins JW; Al-Ansari Z; Shalom DB; Müllertz A; Wågberg L; Löbmann K
    J Control Release; 2016 Dec; 244(Pt A):74-82. PubMed ID: 27847327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellulose nanofibers as excipient for the delivery of poorly soluble drugs.
    Löbmann K; Svagan AJ
    Int J Pharm; 2017 Nov; 533(1):285-297. PubMed ID: 28951349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid nanofoams based on cellulose nanofibers and indomethacin-the effect of processing parameters and drug content on material structure.
    Bannow J; Benjamins JW; Wohlert J; Löbmann K; Svagan AJ
    Int J Pharm; 2017 Jun; 526(1-2):291-299. PubMed ID: 28434935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroretentive inorganic-organic hybrids to improve class IV drug absorption.
    Perioli L; Pagano C
    Int J Pharm; 2014 Dec; 477(1-2):21-31. PubMed ID: 25290811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Improved Understanding of the Interactions between Poorly Soluble Drugs and Cellulose Nanofibers.
    Lombardo S; Chen P; Larsson PA; Thielemans W; Wohlert J; Svagan AJ
    Langmuir; 2018 May; 34(19):5464-5473. PubMed ID: 29715039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spray-dried nanofibrillar cellulose microparticles for sustained drug release.
    Kolakovic R; Laaksonen T; Peltonen L; Laukkanen A; Hirvonen J
    Int J Pharm; 2012 Jul; 430(1-2):47-55. PubMed ID: 22465549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of hot-melt extrusion and injection molding for continuous manufacturing of immediate-release tablets.
    Melocchi A; Loreti G; Del Curto MD; Maroni A; Gazzaniga A; Zema L
    J Pharm Sci; 2015 Jun; 104(6):1971-1980. PubMed ID: 25761921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the coat quality of sustained release pellets by individual pellet dissolution methodology.
    Xu M; Liew CV; Heng PWS
    Int J Pharm; 2015 Jan; 478(1):318-327. PubMed ID: 25435182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide.
    Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X
    Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-emulsifying pellets: relations between kinetic parameters of drug release and emulsion reconstitution-influence of formulation variables.
    Nikolakakis I; Malamataris S
    J Pharm Sci; 2014 May; 103(5):1453-65. PubMed ID: 24596121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified release of furosemide from Eudragits® and poly(ethylene oxide)-based matrices and dry-coated tablets.
    Vlachou M; Geraniou E; Siamidi A
    Acta Pharm; 2020 Mar; 70(1):49-61. PubMed ID: 31677367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoformulations of quercetin and cellulose nanofibers as healthcare supplements with sustained antioxidant activity.
    Li X; Liu Y; Yu Y; Chen W; Liu Y; Yu H
    Carbohydr Polym; 2019 Mar; 207():160-168. PubMed ID: 30599995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilisation of amorphous furosemide increases the oral drug bioavailability in rats.
    Nielsen LH; Rades T; Müllertz A
    Int J Pharm; 2015 Jul; 490(1-2):334-40. PubMed ID: 26026252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
    Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM
    Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Abuse- and Alcohol-Resistant Formulation Based on Hot-Melt Extrusion and Film Coating.
    Jedinger N; Schrank S; Fischer JM; Breinhälter K; Khinast J; Roblegg E
    AAPS PharmSciTech; 2016 Feb; 17(1):68-77. PubMed ID: 26206403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.